Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Apremilast did not work for treating severe alopecia areata.

IL-27 may help prevent hair loss in alopecia areata by promoting immunosuppressive T cells.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Dupilumab effectively treated severe alopecia areata in a child.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Abatacept may help some people with alopecia areata regrow hair.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A(1-7) treatment reduces symptoms of lupus in mice.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.